期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ACTA NEUROLOGICA SCANDINAVICA LetPub Score 6.5
50 ratings
Rate
Reputation 7.6 Influence 5.1 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | ACTA NEUROL SCAND | ||||||||||||||||||||
ISSN | 0001-6314 | ||||||||||||||||||||
E-ISSN | 1600-0404 | ||||||||||||||||||||
h-index | 87 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0404 | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/ane | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wiley-Blackwell Publishing Ltd | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | DENMARK | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1961 | ||||||||||||||||||||
每年文章數 | 45每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 77.20% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0001-6314%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[ACTA NEUROLOGICA SCANDINAVICA] 的評論 | 撰寫評論 |
作者: 西风寻蓉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-16 14:17:23 評論於 So heartbreaking(0) 讚! | 西风寻蓉 |
作者: 风陵松月 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-14 19:05:35 評論於 Review speed: 24.0 Emphasis on research direction: neurology Experience sharing: very slow, it took over two months to allocate an editor, submitted a withdrawal, but the withdrawal was very fast, it was withdrawn in one day(0) 讚! | 风陵松月 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:42:41 評論於 The corresponding author of SCI journal articles does not necessarily have to be only one person, there is no fixed standard regarding the specific number. This is because different SCI journals have different policies on the number of corresponding authors. For SCI journals that only accept one corresponding author, if the article has multiple corresponding authors, the first corresponding author will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. Other requirements apply similarly. In other words, the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person listed first in the author list. However, in collaborative work, it is common to have co-first authors. There is no specific regulation on the number of co-first authors, which is closely related to the workload, length of the paper, publication requirements, and the recognition of the institution. Generally, it is most common for an SCI paper to have 2-4 first authors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:55:16 評論於 Less, mostly full Chinese names(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 21:20:15 評論於 Can the author write their name in Chinese?(0) 讚! | 北国博达 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 13:47:05 評論於 How many corresponding authors can there be at most? How many first authors can there be at most?(0) 讚! | 魂魄彦露 |
作者: 珉林水芸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-28 16:38:36 評論於 Be cautious but optimistic about this journal. Lately, the reviewers have been very particular and raised the standards for articles. It might be harder to slip through with low-quality content(0) 讚! | 珉林水芸 |
作者: Sousa 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-09-28 14:43:33 評論於 I am cautiously optimistic about this journal. The reviewers have been very picky recently and the standards have been raised. (0) 讚! | Sousa |
作者: Sousa 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-09-28 14:41:25 評論於 Be cautious about this journal. Recently, the reviewers have been a lot of picky, and the standard requirements of the article are higher. It is more difficult to fill the water(0) 讚! | Sousa |
作者: 珉林怡瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-28 11:01:59 評論於 Be cautious about this journal, as the recent reviewers have been very strict and have raised the standards for articles. It will be more difficult to submit low-quality work(0) 讚! | 珉林怡瑶 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 12:32:13 評論於 3-point edge, hoping to maintain stability, a slight increase is also good(0) 讚! | 凌霄高洁 |
作者: 普花可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-08-04 09:24:56 評論於 The editor is very conscientious and has been very helpful in improving the paper(0) 讚! | 普花可爱吗 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-08-11 12:12:48 評論於 Review speed: 2.0 | Submission hit rate: 75.0 Experience sharing: It's still easy to publish, although the reviewers have strict requirements. But with comprehensive data, it's still easy to publish(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-09-26 20:45:11 評論於 I strongly agree with the comment below(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us